- Activities: Pain Management & Opioids: A Patient-Centered Approach , Women & Addiction: Screening, Treatment & Whole Person Care 2024, Addressing Intersectionality Within Addiction Medicine, ASAM Clinical Case Scenarios for Payers Package - 2024 Update, NYSAM 2025 Intersection of Science, Treatment and Policy Conference, Pain Management & Opioids: A Patient-Centered Approach, A Primary Care Approach to Treating SUD, ASAM Criteria 4th Edition Skill Building Course - Friday, December 12, 2025, A Primary Care Approach to Treating SUD, Integrating Addiction Medicine with Treatment Courts Course, Treatment of Opioid Use Disorder Care for Pregnant Patients, Readmissions Among Patients with Surgically Managed Drug Use Associated-Infective Endocarditis Before and After the Implementation of an Addiction Consult Team: A Retrospective, Observational Analysis, Closing the Treatment Gap: Integrating Alcohol Use Services & Medications for Alcohol Use Disorder into Primary Care Montana Primary Care Association Enduring Training, The Impact of High Potency Synthetic Opioids on Pharmacotherapies for Opioid Use Disorder: A Scoping Review, The Use and Efficacy of GLP-1 Agonists in Treating Substance Use Disorder in Patients: A Scoping Review, Board Exam Study Tool (BEST) 2024, ASAM State of the Art in Addiction Medicine Course 2024 - Recordings/Enduring Material, Expert Panel Consensus on the Effectiveness and Implementation of Models to Support Post-Hospitalization Care Transitions for People with Substance Use Disorders, Examining the Impact of the Innovative Opioid Court Model on Treatment Access and Court Outcomes for Court Participants, Integration of a Community Opioid Treatment Program Into a Federally Qualified Health Center, Reductions in World Health Organization Risk Drinking Level are Associated with Reductions in Alcohol Use Disorder Diagnosis and Criteria Evidence from an Alcohol Pharmacotherapy Trial, Piloting a Hospital Based Rapid Methadone Initiation Protocol for Fentanyl, High-Dose Buprenorphine Initiation: A Scoping Review, Assessment and Treatment of Alcohol Withdrawal, Striking a Balance: Understanding Pain and Opioids, Alcohol Use Disorder and Common Co-occurring Psychiatric Conditions, Implementing Screening, Brief Intervention and Referral to Treatment (SBIRT) to treat Alcohol Use Disorder, Integrating MAUD and Alcohol Use Services into Primary Care, Pharmacotherapy for Alcohol Use Disorder: Best Practices and Clinical Strategies, Assessment and Management of Alcohol Withdrawal, ASAM Pain & Addiction Essentials Online- Module 1: The Science of Pain & Addiction, ASAM Pain & Addiction Essentials Online - Module 2: Stigma, ASAM Pain & Addiction Essentials Online - Module 3: Screening & Assessment, ASAM Pain & Addiction Essentials Online - Module 4: Treatment - Pharmacological Approaches, Implementing The ASAM Criteria 4th Edition in Utilization Management Course, PCSS-MAUD Motivational Interviewing for Alcohol Use Disorder Treatment, ASAM 55th Annual Conference - Innovations in Addiction Medicine and Science 2024, Prevalence of Kratom Use Disorder among Kratom Consumers, Patients' Perspectives on Discontinuing Buprenorphine for the Treatment of Opioid Use Disorder, Higher First 30-Day Dose of Buprenorphine for Opioid Use Disorder Treatment Is Associated With Decreased Mortality, Alcohol: The World's Most Destructive Drug? Recording, CO*RE REMS Striking A Balance: Podcast Series, Caring for Patients with Opioid Use Disorder: Optimizing Interprofessional Care, PCSS MOUD Online Case-based Learning Collaboratives Session 4: Methadone in the era of Fentanyl, PCSS MOUD Online Case-based Learning Collaboratives Session 3: OUD in Adolescents and Young Adults, PCSS MOUD Case-based Learning Collaboratives Session 2: Hospital Based Approaches to OUD, PCSS MOUD Case-based Learning Collaboratives Session 1: OUD and Pregnancy, ASAM/AAAP Management of Stimulant Use Disorder Webinar Series On-Demand, Clinical Implications of the Relationship Between Naltrexone Plasma Levels and the Subjective Effects of Heroin in Humans, Xylazine Use Among People who Inject Drugs, Philadelphia 2022, Substance Use Overdose Deaths Among Black and Indigenous Women in Wisconsin: A Review, ASAM Clinical Case Scenarios for Payers Package, Prescribe to Save Lives: An Intervention to Increase Naloxone Prescribing Among HIV Clinicians, Investigating Secondary Alcohol Outcomes in a Contingency Management Intervention among American Indian and Alaska Native Adults, Improving Research on Racial Disparities in Access to Medications to Treat Opioid Use Disorders, Impact of Prenatal Cannabis Use Disorder on Perinatal Outcomes, Fentanyl Absorption, Distribution, Metabolism, and Excretion (ADME): Narrative Review and Clinical Significance Related to Illicitly-Manufactured Fentanyl, Examining the Primary Care Experience of Patients with Opioid Use Disorder: a Qualitative Study, Effectiveness and safety of varenicline for smoking cessation: An overview and meta-analysis, Effect of COVID-19 on the Long-term Cardiovascular Outcomes among Patients with Alcohol Use Disorder: A Retrospective Cohort Study Including 45,842 Patients, ASAM CONTINUUM Course - Oregon, Clinician perspectives on delivering medication treatment for opioid use disorder during the COVID-19 pandemic: A qualitative evaluation, ASAM Clinical Case Scenarios for Providers Package, Dispensing Methadone at Hospital Discharge: One Hospital's Approach to Implementing the 72-hour Rule Change, Self-fulfilling Prophecy: Does Structural and Interpersonal Bias Against Pregnant and Postpartum People With Substance Use Disorders Undermine Parenting Identity?, Extended-release Buprenorphine Administered at Discharge in Hospitalized Persons with Opioid Use Disorder: A Case Series, Treatment of Alcohol Use Disorder Course_PCSS-MAUD, FAME Session 8: Stimulant Use Disorder- Monday, June 12, 2023, FAME Session 7: Drug Use in Pregnancy - Monday, May 22, 2023, FAME Session 6: Buprenorphine Treatment in Non-Traditional Settings - Monday, April 17, 2023, Advanced Buprenorphine Education: Best Practices and Emerging Evidence in Opioid Use Disorder Treatment, Use of a Telemedicine Bridge Clinic to Engage Patients in Opioid Use Disorder Treatment, Supporting Self-isolation for COVID-19 With ‘‘Risk Mitigation’’ Prescribing and Housing Supports for People Who Use Drugs, Stigmatizing Terminology for Outcomes and Processes (STOP) in Alcohol Research: A Meta-epidemiologic Assessment of Language Used in Clinical Trial Publications, Moving Away From a ‘‘One Size Fits All’’ Model: Ensuring Opioid Stewardship Includes People Who Use Drugs, Injecting Opioid Use Disorder Treatment in Jails and Prisons: The Potential of Extended-release Buprenorphine in the Carceral Setting, Characterizing Substance Use Disorders among Transgender Adults Receiving Care at a Large Urban Safety Net Hospital, Primary Care Associated With Follow Up Viral Load Testing in Patients Cured of Hepatitis C Infection With Direct Acting Antivirals at a Multidisciplinary Addiction Treatment Program: Insights From a Real-World Setting, Injection Drug Use and Healthcare Utilization in Patients Newly Diagnosed With HIV, Gender Differences in Psychiatric and Behavioral Health Burden Among Adults With Alcohol and Other Substance Use Disorders in the United States, ASAM CO-Triage Enduring Course
- Provider Ship: 1
- Provider Address: Rockville, MD, USA
- Activity Link: http://www.asam.org
- Number of Activities Reported Last Year: 228
- Name of Contact: Caitlyn Keenan
- Phone Number: (301) 547-4138
- Address: 11400 Rockville Pike, Suite 200, Rockville, MD, 20852, USA
- Accreditation Status: Joint Accreditation
- Accredited Provider: Joint Accreditation
- Activity Format: Enduring Material, Journal CME/CE, Live Course, Other/Blended Learning, Regularly Scheduled Series
Deprecated: File Theme without comments.php is deprecated since version 3.0.0 with no alternative available. Please include a comments.php template in your theme. in /nas/content/live/sleepliteracy/wp-includes/functions.php on line 6121
Leave a Reply